nevirapine hepatotoxicity

Nurse advised me to take ZIDOLAM-N as PEP for 28 days. After continuing for 3 days i visited a doctor and he told me that Nevirapine should not be used for PEP but since i already started the PEP, he advised me to continue the same medication and asked to monitor closely the side effects of the drug. Now today Friday i am experiencing some pain in the upper abdomen. Is there any possibility that i can change the PEP drug to avoid nevirapine, please Suggest?

I am going to the US in 2 days, if I cannot find a way to get pep here, could I take his ARVs just until then as a temporary measure? He says he takes nevirapine and tenofivir/lamivudine blend. Any advice really appreciated! If my risk is very low I would prefer not to take pep but I suspect I may be best advised to do so. If it makes a difference, I am prone to have a tiny amount of blood(I think from tears) on toilet paper when I use the bathroom so that may make it more risky? Thanks!

Tuberculosis was more common in alcoholic and Child class C cirrhosis (Table 1). Antituberculosis therapy (ATT) is associated with hepatotoxicity in 10%. Hepatotoxicity requires withdrawal, modification, and sequential reintroduction to achieve cure of tuberculosis. Using such hepatotoxic drugs in presence of cirrhosis or advanced liver disease is a challenge.

Although clinically significant liver injury is extremely rare from statins, mild increases in liver enzymes can occur in 1%–3% of patients. Because of the concern of possible hepatotoxicity, statins are labeled as contraindicated in patients with liver disease. Given the prevalence of liver diseases in the population, such as nonalcoholic fatty liver disease (NAFLD), hepatitis C (HCV), and others, many patients have not benefitted from the cardiovascular protective effects of statins.

i believe there is some data showing that naturally it can some hepatotoxicity

In adults and adolescents, hepatotoxicity may occur following ingestion of greater than 7.5 to 10 g (ie, 24 regular-strength or 15 extra-strength caplets or tablets) over a period of 8 hours or less. So, the pain may not be related to your medications. Hope this helped and do keep us posted.

Viagra has some side effects, including hepatotoxicity, acute liver injury. It seems not useful for liver, damaged by HCV. See http://livertox.nih.gov/Sildenafil.

Alcohol consumption has been associated a higher risk of developing isoniazid-induced hepatotoxicity. Isoniazid should be eliminated from your body about 20-24 hours after your last dose.

As for the two doses, studies indicate that 28 days is required to give the maximum benefit. Side effects I would suspect will be minimal. Truvada carries a risk of hepatotoxicity but this is not a concern after two doses. Your risk is fairly low so take a 4th Gen Duo test at 28 days to give you some relief.

Choanal and esophageal atresia of fetus in MMI-treated and maternal hepatotoxicity in PTU-treated pregnancies are of utmost concern. Maintaining free thyroxine concentration in the upper one-third of each trimester-specific reference interval denotes success of therapy. MMI is the mainstay of the treatment of post partum hyperthyroidism, in particular during lactation." http://www.ncbi.nlm.nih.gov/pubmed/21389085 IIRC about 30% of women have thyroid enlargement during pregnancy.

No uniform pattern of hepatotoxicity has been identified and severity may range from asymptomatic elevations of serum liver enzymes to hepatic failure and death. Exact estimates on how frequent adverse hepatic reactions occur as a result of DSs cannot be provided. Liver injury from DSs mimicking other liver diseases is increasingly recognized.

In fact, many NSAIDs have been withdrawn from the market due to their hepatotoxicity. All NSAIDs have the potential to cause liver injury. However, some NSAIDs are more hepatotoxic than others. NSAIDs presently on the market that have been frequently associated with liver injury are aspirin (ASA) diclofenac (Voltaren) sulindac (Clinoril) Ibuprofen (Motrin) has been reported to cause severe liver injury in people with hepatitis C.

Although investigative research of animal models in cocaine metabolism and associated liver cell injury has been fairly extensive during the past 10 yr, little evidence of hepatotoxicity has been documented in man. We report a case of fulminant hepatic failure and acute rhabdomyolysis resulting from cocaine use.

Nevirapine hepatotoxicity

Common Questions and Answers about Nevirapine hepatotoxicity

viramune